Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals ALNY
$ 248.37 6.02%

Квартальный отчет 2024-Q3
добавлен 31.10.2024

report update icon

Alnylam Pharmaceuticals Мультипликаторы 2011-2024 | ALNY

Мультипликаторы по годам Alnylam Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-42.3 -21.0 -21.9 -19.8 -14.2 -10.8 -24.2 -7.7 -20.0 -19.3 -59.3 -11.3 -8.2

P/S

10.2 22.9 22.1 34.6 57.4 109.7 132.2 66.9 140.9 137.8 112.1 17.9 5.7

EPS

-3.5 -9.3 -7.2 -7.5 -8.1 -7.6 -5.4 -4.8 -3.5 -4.8 -1.4 -2.1 -1.4

EV (Enterprise Value)

21.9 млрд 26.6 млрд 20.9 млрд 18.9 млрд 13 млрд 8.07 млрд 11.5 млрд 3.31 млрд 5.73 млрд 7.04 млрд 5.38 млрд 1.3 млрд 567 млн

EBITDA per Share

-1.83 -6.09 -5.58 -6.9 -8.1 -8.03 -5.37 -4.78 -3.3 -2.32 -1.34 -1.08 -1.17

EV/EBITDA

-31.5 -22.5 -13.6 -9.7 -23.2 -7.6 -20.3 -40.0 -63.3 -21.0 -8.1

PEG

2.25 -4.12 -3.82 -1.07 2.0 0.27 1.84 0.2 -0.69 0.08 -1.89 0.2 0.27

P/B

-84.5 -150.0 31.8 16.8 8.8 6.3 6.7 3.4 4.6 7.4 19.6 8.9 4.0

P/CF

178.9 -43.8 -29.1 -27.7 -30.1 -11.9 -24.4 -8.5 -28.7 -39.9 -72.8 -9.7 -5.4

ROE %

199.53 714.91 -144.99 -84.46 -61.59 -58.49 -27.79 -44.57 -22.94 -38.49 -33.00 -79.08 -48.86

ROA %

-11.49 -31.90 -23.41 -25.19 -37.00 -48.36 -24.61 -32.48 -20.92 -33.38 -21.22 -36.87 -20.45

ROCE %

127.89 496.18 -120.48 -81.52 -45.99 -58.39 -27.02 -37.54 -22.35 -18.72 -25.35 -26.58 -27.28

Current Ratio

0.9 1.0 1.2 1.4 4.9 6.7 12.2 5.1 17.8 7.8 4.7 2.6 1.9

DSO

13.2 18.6 23.1 17.9 71.4 91.4 138.0 180.6 73.7 288.3 32.9 0.6 6.5

DIO

148.4 280.3 256.4 323.6 820.6 4875.0 - - - - - - -

DPO

104.5 223.3 199.0 250.6 726.5 12094.0 - - - - - - -

Операционный цикл

161.6 298.9 279.5 341.6 892.1 4966.4 - - - - - - -

Финансовый цикл

57.0 75.6 80.5 91.0 165.6 -7127.6 - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Alnylam Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.87 -0.13 -0.52 - 1.18 -2.21 -1.4 - -3.32 -2.29 -2 - -1.72 -1.61 -1.71 -2.09 -2.18 -1.56 -1.62 -2.47 -1.92 -2.02 -1.73 -2.09 -2.43 -1.63 -1.41 -1.48 -1.34 -1.34 -1.25 -1.32 -1.21 -1.05 -1.21 -1.07 -0.91 -0.85 -0.62 -0.28 -0.58 -0.58 -3.7 -0.51 -0.48 -0.29 -0.15 -1.2 -0.38 -0.25 -0.25 -0.33 -0.31 -0.33 -0.38

EBITDA per Share

- - -0.24 - - - -1.09 - -1.87 -1.59 -1.14 - -1.22 -1.24 -1.48 - -1.73 -1.59 -1.8 - -1.88 -2.11 -1.75 - -2.47 -1.86 -1.44 - -1.26 -1.3 -1.2 - -1.1 -0.98 -1.24 - -0.76 -0.76 -0.59 - -0.48 -0.52 -3.93 - -0.39 -0.27 -0.13 - -0.22 -0.14 -0.19 - -0.2 -0.25 -0.34

ROE %

146.82 402.58 -80.46 45.71 645.85 1335.06 1109.85 382.65 355.59 -271.60 -136.24 -70.89 -94.86 -92.73 -88.15 -84.46 -79.69 -69.26 -66.88 -61.59 -58.63 -62.98 -60.29 -58.49 -50.30 -38.42 -32.56 -27.79 -32.01 -36.36 -39.45 -44.57 -39.47 -34.23 -30.11 -22.94 -18.05 -16.67 -15.71 -38.49 -48.18 -54.46 -56.47 -33.00 -67.43 -70.99 -73.94 -79.08 -44.81 -41.48 -43.54 -48.86 -11.22 -11.72 -13.80

ROA %

-0.95 5.55 -2.14 -9.40 -20.88 -36.21 -35.10 -25.48 -31.37 -18.78 -24.18 -17.44 -24.59 -26.14 -26.00 -25.19 -29.57 -30.85 -34.75 -37.00 -38.89 -45.76 -46.98 -48.36 -42.06 -32.65 -28.20 -24.61 -26.42 -28.50 -29.70 -32.48 -30.08 -27.37 -25.41 -20.92 -16.36 -14.90 -13.80 -33.38 -39.10 -42.08 -42.32 -21.22 -35.15 -34.88 -35.06 -36.87 -20.32 -18.23 -18.63 -20.45 -4.70 -4.90 -5.78

ROCE %

-1931.90 -1823.14 -181.76 -14.84 366.66 877.10 711.90 236.04 212.00 -193.53 -101.77 -61.27 -83.43 -81.56 -84.00 -62.41 -77.44 -70.32 -67.17 -44.58 -64.13 -68.65 -67.00 -45.65 -52.77 -40.34 -32.39 -19.97 -31.56 -36.03 -39.26 -33.60 -39.79 -34.39 -30.11 -16.09 -20.92 -19.55 -18.59 -38.37 -50.30 -57.39 -60.47 -23.43 -36.97 -38.58 -39.70 -30.66 -41.21 -38.21 -40.33 -34.94 -10.54 -11.12 -13.29

Current Ratio

1.0 1.0 0.9 0.9 1.0 0.9 0.9 1.0 1.0 - 1.1 1.2 1.3 1.3 1.4 1.4 1.4 1.4 1.4 2.5 2.5 2.5 2.5 5.8 5.8 5.8 5.8 8.7 8.7 8.7 8.7 3.7 3.7 3.7 3.7 11.4 11.4 11.4 11.4 7.5 7.5 7.5 7.5 2.8 2.8 2.8 2.8 1.9 1.9 1.9 1.9 1.7 1.7 1.7 1.7

DSO

60.4 43.6 59.9 - 33.2 63.0 65.4 - 3.8 4.8 20.7 - 14.0 11.0 13.5 18.7 24.3 29.4 22.2 19.0 19.4 30.5 28.2 24.4 248.1 17.2 82.6 58.5 80.2 141.5 138.0 - - - - - - - - - - - - - - - - - -5.9 -8.3 -80.7 - -286.8 -132.4 -

DIO

89.0 120.7 153.0 - 112.7 140.7 287.2 - 144.3 105.2 320.7 - 296.0 238.7 295.6 - 329.5 375.7 451.2 - 986.3 1188.6 1096.2 - 16030.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

80.6 103.2 111.7 - 76.7 73.9 176.6 - 50.7 73.6 249.6 - 151.3 148.5 192.9 - 227.7 259.6 349.3 - 873.2 1052.2 1493.9 - 39769.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

149.4 164.3 212.9 - 145.8 203.7 352.6 - 148.1 110.0 341.4 - 310.0 249.7 309.1 18.7 353.8 405.1 473.4 19.0 1005.8 1219.0 1124.4 24.4 16278.8 17.2 82.6 58.5 80.2 141.5 138.0 - - - - - - - - - - - - - - - - - -5.9 -8.3 -80.7 - -286.8 -132.4 -

Финансовый цикл

68.9 61.1 101.2 - 69.2 129.8 176.0 - 97.4 36.4 91.8 - 158.8 101.2 116.2 18.7 126.1 145.5 124.1 19.0 132.6 166.8 -369.6 24.4 -23490.2 17.2 82.6 58.5 80.2 141.5 138.0 - - - - - - - - - - - - - - - - - -5.9 -8.3 -80.7 - -286.8 -132.4 -

Все данные представлены в валюте USD